UY37907A - 3-fenilquinazolin-4 (3h)-onas sustituidas y sus usos - Google Patents
3-fenilquinazolin-4 (3h)-onas sustituidas y sus usosInfo
- Publication number
- UY37907A UY37907A UY0001037907A UY37907A UY37907A UY 37907 A UY37907 A UY 37907A UY 0001037907 A UY0001037907 A UY 0001037907A UY 37907 A UY37907 A UY 37907A UY 37907 A UY37907 A UY 37907A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- preparation
- phenylquinazolin
- unes
- replaced
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 5
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- WAIHFZPSLVDBRV-UHFFFAOYSA-N 3-phenylquinazolin-4-one Chemical class C1=NC2=CC=CC=C2C(=O)N1C1=CC=CC=C1 WAIHFZPSLVDBRV-UHFFFAOYSA-N 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003176 fibrotic effect Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17193995 | 2017-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY37907A true UY37907A (es) | 2019-04-30 |
Family
ID=59997232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001037907A UY37907A (es) | 2017-09-29 | 2018-09-27 | 3-fenilquinazolin-4 (3h)-onas sustituidas y sus usos |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR112840A1 (fr) |
| TW (1) | TW201922724A (fr) |
| UY (1) | UY37907A (fr) |
| WO (1) | WO2019063704A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021167883A1 (fr) * | 2020-02-21 | 2021-08-26 | The Children's Medical Center Corporation | Méthode pour le traitement de l'asthme ou d'une maladie allergique |
| CN112370529B (zh) * | 2020-11-30 | 2022-11-11 | 中国药科大学 | 一种治疗肺动脉高压的复方制剂与制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966781A (en) | 1970-12-17 | 1976-06-29 | Merck Sharp & Dohme (I.A.) Corporation | Deuteration of functional group-containing hydrocarbons |
| ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
| GB0124627D0 (en) | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| EP1553947A4 (fr) | 2002-10-21 | 2006-11-29 | Bristol Myers Squibb Co | Quinazolinones et derives de celles-ci comme inhibiteurs du facteur xa |
| MXPA06014696A (es) * | 2004-06-15 | 2007-02-12 | Astrazeneca Ab | Quinazolonas sustituidas como agentes anticancerosos. |
| EP2091947A2 (fr) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Activateurs de glucokinase |
| WO2012112363A1 (fr) | 2011-02-14 | 2012-08-23 | Merck Sharp & Dohme Corp. | Inhibiteurs de cystéine protéases, les cathepsines |
| SG11201507615SA (en) | 2013-03-20 | 2015-10-29 | Bayer Pharma AG | 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders |
| JP6492012B2 (ja) * | 2013-12-06 | 2019-03-27 | カルナバイオサイエンス株式会社 | 新規キナゾリン誘導体 |
-
2018
- 2018-09-27 WO PCT/EP2018/076287 patent/WO2019063704A1/fr active Application Filing
- 2018-09-27 TW TW107134050A patent/TW201922724A/zh unknown
- 2018-09-27 UY UY0001037907A patent/UY37907A/es not_active Application Discontinuation
- 2018-09-27 AR ARP180102771A patent/AR112840A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR112840A1 (es) | 2019-12-18 |
| TW201922724A (zh) | 2019-06-16 |
| WO2019063704A1 (fr) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP19030002A (es) | 1,2,4-triazolonas 2,4,5-trisustituidas | |
| CL2019002255A1 (es) | 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas. | |
| DOP2019000117A (es) | Nuevos derivados de quinolina | |
| CO2020001244A2 (es) | Derivados de quinolina para tratar infecciones con helmintos | |
| UY37460A (es) | 1,2,4-triazolonas con anelación en 4 y 5 | |
| CL2018002920A1 (es) | Nuevos derivados de pirazolopirimidina | |
| CO2019014484A2 (es) | Nuevos derivados de azaquinolina | |
| CO2019011877A2 (es) | Nuevos derivados de pirazol bicíclicos | |
| ECSP20008441A (es) | Dihidrooxadiazinonas | |
| CO2020013876A2 (es) | Nuevos derivados de quinolina | |
| UY37971A (es) | Derivados de indol macrocíclicos sustituidos | |
| UY36460A (es) | Pirazolpiridinaminas | |
| UY38228A (es) | Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer | |
| DOP2020000100A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3 | |
| BR112019006880A2 (pt) | compostos e composições para tratamento de leishmaniose e métodos de diagnóstico e tratamen-to usando os mesmos | |
| UY38816A (es) | Nuevos derivados de isoquinolina | |
| UY37907A (es) | 3-fenilquinazolin-4 (3h)-onas sustituidas y sus usos | |
| CL2019001004A1 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos. | |
| UY36983A (es) | Pirazolopiridinaminas sustituidas | |
| UY37530A (es) | [4-(fenilsulfonil)piperazin-1-il](1h-1,2,3-triazol-4-il)metanonas | |
| UY37032A (es) | Compuestos de heteroarilbenzimidazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20231114 |